Elevated chemerin induces insulin resistance in human granulosa-lutein cells from polycystic ovary syndrome patients
Using expired BAC water for reconstitution introduces potential microbial concerns independent of the peptide
This protein may use the morpheein model of allosteric regulation
These are legitimate benefits, but they don't alter the core lipotropic mechanism
Several GLS inhibitors have been developed, among which CB-839 is currently undergoing clinical trials as a potent, orally bioavailable GLS-selective inhibitor for the treatment of various cancers, including TNBC, NSCLC, and colon cancer (NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600, NCT03057600)